Lakefront Biotherapeutics | GLPG - Ebit

Stock Price
23.40
Daily Change
-0.38 -1.60%
Monthly
-5.26%
Yearly
-5.11%
Q2 Forecast
22.89

Lakefront Biotherapeutics reported EUR-63.7M in EBIT for its fiscal quarter ending in March of 2026.





Ebit Change Date
argenx SE USD 394M 22.86M Mar/2026
AstraZeneca USD 7.11B 4.14B Mar/2026
Biogen USD 514.3M 502.8M Mar/2026
Genmab DKK 260M 199M Dec/2025
Gilead Sciences USD 2.68B 284M Mar/2026
GlaxoSmithKline GBP 2.29B 856M Mar/2026
GRIFOLS EUR 249M 103.11M Mar/2026
Hikma Pharmaceutical USD 348M 31M Dec/2025
Incyte USD 344.17M 39.71M Mar/2026
Merck EUR 474M 738M Dec/2025
Neurocrine Biosciences USD 214.6M 13.3M Mar/2026
Novartis USD 4.18B 118M Mar/2026
Roche Holding CHF 9.56B 2.1B Dec/2025
Sanofi EUR 1.94B 239M Mar/2026
UCB EUR 1.29B 571M Dec/2025
Vertex Pharmaceuticals USD 1.14B 124.5M Mar/2026